New diabetes medications drive up costs and stymie formulary design
Reinke, T.
Managed Care 21(4): 16-18
2012
ISSN/ISBN: 1062-3388 PMID: 22590782 Document Number: 660602
Document emailed within 1 workday
Related Documents
Wang, Y.R.; Pauly, M.V. 2005: Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors Managed Care Interface 18(8): 39-45Abourjaily, P.; Gouveia, W.A.; Selker, H.P.; Zucker, D.R. 2005: Evaluating the nondrug costs of formulary coverage restrictions Managed Care 14(8): 50-7 62
Dowell, J.S.; Snadden, D.; Dunbar, J.A. 1995: Changing to generic formulary: how one fundholding practice reduced prescribing costs Bmj 310(6978): 505-508
Kile, D.M.; McGrath, M.E.; Schindel, L.P. 1987: Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs Hospital Formulary 22(2): 176; 178, 181
Von Ferber, L.; Köster, I.; Hauner, H. 1996: Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard Medizinische Klinik 91(12): 802-808
Davis, W. 2014: Waste and missed opportunities drive costs upward Clinical Advances in Hematology and Oncology: H&o 12(1): 65
Miller, E.M. 2017: Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Role of Injectable Medications in Type 2 Diabetes Treatment Journal of Family Practice 66(10 Suppl): S4-S6
1991: Planning indicators. Compound factors drive health care costs up Health Care Strategic Management 9(12): 23
King, A.B.; Meyer, G.S. 1995: Medicaid costs drive state health care reform--Part Ii Nutrition 11(6): 771-772
Weiss, R.; Bazalo, G.; Clark, N.; Forma, F.; Ingram, G.; Alemayehu, B. 2007: Correlation of HEDIS diabetes health plan score with utilization of diabetes medications Managed Care Interface 20(10): 14-17
Jurman, R.J.; Davis, J.M. 1991: Comparisons of the costs of psychotropic medications: an update Psychiatric Medicine 9(2): 349-359
Shendurnikar, N.; Javadekar, B.B.; Gohil, J.R. 1992: Practitioners' knowledge of prescribing costs of pediatric medications Indian Pediatrics 29(1): 91-92
Trye, P.; Jackson, R.; Yee, R.L.; Beaglehole, R. 1996: Trends in the use of blood pressure lowering medications in Auckland, and associated costs, 1982-94 New Zealand Medical Journal 109(1026): 270-272
Iyoda, K.; Okazaki, T.; Ogawa, K.; Murao, S. 2006: Driving license for persons with epilepsy--to drive or not to drive-- No to Hattatsu 38(5): 375-376
Lubetzki, J. 1976: Hypoglycemic medications and vascular complications of diabetes mellitus. Current controversy La Revue du Praticien 26(45): 3173-3183
O'Dell, K.; O'Dell, M.; Taylor, J. 2008: Access to medications and intermediate markers of health outcomes of a clinic population of patients with diabetes Journal of the Mississippi State Medical Association 49(6): 170-173
Lutz, S. 1990: Bush, HHS stymie plan to equalize Medicare rates in Nebraska, Okla Modern Healthcare 20(50): 6-7
Britt, D.M.I.; Day, G.S. 2016: Over-Prescribed Medications, Under-Appreciated Risks: a Review of the Cognitive Effects of Anticholinergic Medications in Older Adults Missouri Medicine 113(3): 207-214
Salas Campos, L.; Fernández Mansilla, M.; Estudillo Pérez, V. 2006: "Ready to use" medications. a guide to limit errors when using medications Revista de Enfermeria 29(9): 27-32
Laville, M. 1996: Diabetes, dialysis, health costs Nephrologie 17(6): 319-320